Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05841095
Status:
RECRUITING
Last Update Posted:
2024-02-20
First Post:
2023-03-27
Brief Title:
Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104
Sponsor:
Erasmus Medical Center
Organization:
Erasmus Medical Center
Organization Data
Organization:
Erasmus Medical Center
Class:
OTHER
Study ID:
MEC22-0600
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Erasmus Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Dave Sprengers
Responsible Party Title:
Priniciple Investigator MD PhD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Erasmus Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| ISA Pharmaceuticals BV | INDUSTRY |